EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
1.25
↓ 77% below average
Average (9y)
5.35
Historical baseline
Range
High:19.41
Low:1.25
CAGR
-13.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.25 | -62.1% |
| 2023 | 3.29 | +142.7% |
| 2022 | 1.36 | -29.0% |
| 2021 | 1.91 | -58.1% |
| 2020 | 4.56 | -76.5% |
| 2019 | 19.41 | +135.9% |
| 2018 | 8.23 | +81.5% |
| 2017 | 4.53 | +5.7% |
| 2016 | 4.29 | -9.6% |
| 2015 | 4.74 | - |